Cataract Surgery in Warfarin Patients: Continue Anticoagulation
Patients on warfarin with a low INR (within therapeutic range) should continue their anticoagulation without interruption for cataract surgery, as the risk of thromboembolic events from stopping warfarin far outweighs the minimal risk of clinically insignificant bleeding.
Key Management Principles
Continue Warfarin Through Surgery
The evidence strongly supports continuing warfarin during cataract surgery when using topical or sub-Tenon's anesthesia 1, 2. Multiple studies demonstrate that while bleeding events may be slightly more common (odds ratio 3.26), these are almost exclusively minor complications like dot hyphemas or subconjunctival hemorrhages that do not affect visual outcomes 3.
Critical point: No patient in the reviewed studies experienced compromised visual acuity related to bleeding events when warfarin was continued 3, 4.
INR Management
- Target range: Keep INR at the low end of therapeutic range (typically 2.0-3.0) 1
- Timing: Check INR just prior to surgery 1
- Acceptable range: Studies show safety with INR up to 2.4, with mean preoperative INR of 1.52 5
- Do NOT routinely give vitamin K if INR is elevated (>1.5) 1-2 days before surgery, per ACCP guidelines 6
Anesthesia Selection Matters
Use topical or intracameral anesthesia rather than sharp needle blocks 2, 7. This approach minimizes bleeding risk even in anticoagulated patients 4, 8.
Post-Operative Warfarin Resumption
If warfarin was interrupted (which is generally unnecessary for cataract surgery):
- Resume at the usual maintenance dose, not double-dose 6
- Doubling the dose may achieve therapeutic INR faster but creates practical concerns and potential for over-anticoagulation 6
Evidence Quality
The research consistently shows:
- Bleeding incidence: 10-25% in warfarin patients vs 11% in controls 9, 3
- Clinical significance: Zero cases of vision-threatening hemorrhage 5, 4
- Thromboembolic events: None reported when warfarin continued 9, 5
Common Pitfalls to Avoid
Do not stop warfarin - The thromboembolic risk (stroke, MI, valve thrombosis) is far more dangerous than minor surgical bleeding 1, 5, 2
Do not use sharp needle anesthesia - Stick with topical/intracameral techniques in anticoagulated patients 2, 7
Do not give routine preoperative vitamin K - This is specifically recommended against by ACCP guidelines and may cause resistance to post-operative re-anticoagulation 6
Do not assume "low INR" means subtherapeutic - If the patient's therapeutic range is 2.0-3.0, an INR of 2.0-2.5 is appropriate and safe for surgery 1, 5
Specific Algorithm
For patients on warfarin requiring cataract surgery:
- Check INR within 24-48 hours before surgery
- If INR is within therapeutic range (typically 2.0-3.0): Proceed with surgery, continue warfarin
- Use topical or sub-Tenon's anesthesia only
- Ensure surgical site is accessible for local hemostasis if needed 1
- No routine vitamin K administration 6
- Continue usual warfarin dose postoperatively 6
The question mentions "low INR" - if this means subtherapeutic (below 2.0 in most cases), this actually represents a safer bleeding profile for surgery while still providing some anticoagulation. Continue warfarin at the usual dose and proceed with surgery using topical anesthesia.